An Open-label Phase 3b Study of Ivosidenib in Combination With Azacitidine in Adult Patients Newly Diagnosed With IDH1m Acute Myeloid Leukemia (AML) Ineligible for Intensive Induction Chemotherapy.
Clinical trial NCT05907057 · RECRUITING
Trial details
- NCT number
- NCT05907057
- Sponsor
- Servier Affaires Médicales
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-14
- Primary completion
- 2027-10-15
- Enrollment
- 245
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.